Sitemap | Medicalalgorithms.com

Sitemap

Coagulation

Protocols for Heparin Therapy Based on aPTT
Protocol for Heparin Therapy Based on Heparin Dose Response Curve
Resistance to Heparin Therapy
Heparin Anticoagulation During Slow, Continuous Therapies for Renal Failure
Protocol of Smith and Wheeler for Dosing Unfractionated Heparin Based on Plasma Anti-Factor Xa Levels
Factor VIII Levels and Hemophilia A
Clinical Findings in a Patient with an Hereditary Deficiency of Factor XIII
Clinical Findings in a Patient with an Hereditary Deficiency of Factor XII
Clinical Findings in a Patient with an Hereditary Deficiency of Factor XI
Titer of VIII Inhibitor and Response to Factor VIII Replacement in Hemophilia A
Indications for Screening a Patient with Hemophilia A for a Factor VIII Inhibitor
Clinical Findings in a Patient with a Factor XI Inhibitor
Clinical Findings in a Patient with an Hereditary Deficiency of Factor VII
Clinical Findings in a Patient with an Hereditary Deficiency of Factor X
Clinical Findings in a Patient with an Acquired Deficiency of Factor X
Clinical Findings in a Patient with an Hereditary Deficiency of Factor V
Clinical Findings in a Patient with an Acquired Factor V Deficiency
Clinical Findings in a Patient with an Hereditary Deficiency of Factor II (Prothrombin)
Identification of a Patient with a Hereditary Deficiency of Prekallikrein and/or High Molecular Weight Kininogen
Clinical Features of Hereditary Deficiency of Factor IX (Hemophilia B)
Hemophilia A or B in a Female
Types of Familial Multiple Coagulation Factor Deficiency (FMFD)
Clinical Features of a Factor IX Inhibitor
Inhibitors to Coagulation Factors and Bleeding Associated with the Use of Bovine Topical Thrombin
Correction of a Coagulation Factor Deficiency By Liver Transplantation
Coagulation Factor Deficiency Following Liver Transplantation
Perioperative Management of a Patient with Hereditary Deficiency of Factor XII
Predicting the Bleeding Time from the Platelet Count
Tourniquet Test (Capillary Fragility Test of Hess, Rumpel-Leede Test)
Algorithm of Vadher et al for Dosing Oral Anticoagulants and Scheduling Followup
Dosing Algorithm of Ryan et al (Coventry or Warwickhire Method) for Oral Anticoagulants
Dosing Oral Anticoagulants Using the Hillingdon Method
Induction and Maintenance Dosing of Oral Anticoagulants Using the Method of Fennerty et al
Adjustment in the Daily Warfarin Dose for a Patient Receiving Long-Term Amiodarone Therapy
Predictor Score of Absher et al for a Patient's Warfarin Dose Requirement
Model of Tham et al for Determining the Daily Dose of Warfarin to Give to an Asian Based on Genotypic Analysis of Vitamin K Eposoxide Reductase Complex and Cytochrome P450 2C9
Models of Sconce et al for Determining the Daily Dose of Warfarin to Give That Include Genotypic Analysis of CYP2C9 and VKORC1
Model of Kamali et al for Determining Warfarin Dose in a Patient Based on CYP2C9 Genotype
Warfarin (Coumadin) Resistance
Model of Zhu et al for Determining a Patient's Daily Dose Requirement for Warfarin
Parenteral Administration of Warfarin
Risk Factors of Hylek et al for Excessive Warfarin Anticoagulation
Algorithm of Dunn for the Perioperative Management of a Patient Receiving Oral Anticoagulation
Antithrombotic Therapy for a Patient with a Mechanical Heart Valve
Antithrombotic Therapy for a Patient with a Prosthetic Heart Valve
Warfarin Resistance Associated with Poor Intestinal Absorption
Prophylactic Oral Therapy with Dabigatran Following Hip or Knee Arthroplasty
Prophylactic Oral Therapy with Rivaroxaban Following Hip or Knee
Regression Model of Wells et al for Predicting Warfarin Dose Using Pharmacogenetics
International Normalized Ratio (INR)
Estimating the Percent Prothrombin Complex Activity from the INR
Indications for Using an Alternative Method to the PT or INR for Monitoring Warfarin Therapy in a Patient with a Lupus Anticoagulant
PT, INR and aPTT in a Patient Receiving Both Heparin and Warfarin
Adjusting the Amount of Specimen Anticoagulant for an Elevated Hematocrit
Activated Protein C (APC) Resistance Ratio
Protein S and C Levels in Patients Receiving Coumadin Therapy
Neonatal Purpura Fulminans Associated with Congenital Protein C Deficiency
Conditions Associated with Acquired Deficiency of Protein S and/or Protein C
Beta-Thromboglobulin to Platelet Factor 4 Ratio
Criteria of Ginsberg for the Probability of Deep Vein Thrombosis
Screening Tests for Exclusion of Deep Vein Thrombosis
Risk of Deep Vein Thrombosis and Pulmonary Embolism in a Surgical Patient
Risk Factor Score of Weiss and Bernstein for Venous Thromboembolism in Obstetric Patients
Indications for Placement of an Inferior Vena Cava Filter in a Patient with Deep Vein Thrombosis
Clinical Prediction Index of Kahn et al for Deep Vein Thrombosis in Patients with Leg Symptoms
Risk Assessment Profile (RAP) of Greenfield et al for Venous Thromboembolism in Adult Trauma Patients
Indications for Prophylactic Placement of an Inferior Vena Cava Filter in a Trauma Patient
Discriminant Formula of Clayton et al for Prediction of Post-Operative Deep Vein Thrombosis
Factors Justifying an Extensive Evaluation in a Patient with Idiopathic Deep Vein Thrombosis
Pseudothrombophlebitis Associated with a Baker's Cyst
Reporting Standards of the International Consensus Committee on Chronic Venous Disease for Risk of Acute Lower Extremity Thrombosis
Reporting Standards of the International Consensus Committee on Chronic Venous Disease for Describe the Extent of Thrombosis in a Lower Extremity
Modification of Cafferata et al to the Reporting Standards of the ICS on CVT for Risk of Acute Lower Extremity Thrombosis Associated with Trauma
Duration of Therapy for a Patient with Deep Vein Thrombosis
Exclusion Criteria for Home (Outpatient) Therapy of Acute Deep Vein Thrombosis
Algorithm of Gorman et al for the Investigation of Deep Vein Thrombosis
Diagnosis of Thrombosis of the Axillary and Subclavian Veins
Diagnosis of Paget-von Schroetter Syndrome with Axillosubclavian Venous Thrombosis (Exertional Thrombosis, Venous Type Thoracic Outlet Obstruction)
Algorithm of Knudson et al for Venous Thromboembolism Prophylaxis in a Trauma Patient
Risk Factors of Vavilala et al for Venous Thromboembolism in Pediatric Trauma Patients
Predictors of Goldenberg et al for a Poor Outcome in a Child with Thrombosis
Clinical Findings Associated with Severe Deep Vein Thrombosis in a Lower Extremity (Phlegmasia and Venous Gangrene)
Risk Factors of Cook et al for Deep Vein Thrombosis in a Patient in the Intensive Care Unit (ICU)
Predictors of Iskander et al for Propagation of Deep Vein Thrombosis Above the Knee in a Trauma Patient
Risk Factors of Hansson et al for Recurrent Deep Vein Thrombosis
Risk Assessment Scorecard of Lutz et al for Venous Thromboembolism
Scoring System of Bjorgell and Robertson for Grading the Extent of Deep Leg Vein Thrombosis
Venographic Classification of Marder et al for Quantifying Venous Thrombosis in a Leg
Venographic Classification of Marder et al for Quantifying Venous Thrombosis in an Arm
Venographic Classification of Arnesen et al for Quantifying Venous Thrombosis in a Leg
Swelling to Pain (S/P) Ratio of Lundh and Fagher for Evaluating a Patient for a Deep Vein Thrombosis in the Lower Leg
Risk Score of Rogers et al for Predicting Venous Thromboembolism in a General or Vascular Surgery Patient Based on the Patient Safety in Surgery Study
Clinical Features of Mondor's Disease (Thrombophlebitis in a Subcutaneous Vein of the Breast)
Risk Factors for Deep Vein Thrombosis in an HIV-Positive Patient
Risk Factors of Adams et al for Thromboembolic Disease in a Patient Following Trauma
Protocol of Adams et al for Prevention of Thromboembolic Disease in a Patient After Major Trauma
Risk Factors of Marik and Plante for Venous Thromboembolism Following Cesarean Section
Clinical Rule of Toll et al for Ruling Out Deep Vein Thrombosis of the Leg in Primary Care
Risk Score of Lindqvist et al for Postpartum Thromboembolism
Thrombosis and JAK2 Mutation Status
Risk Factors of Rubin-Asher et al for Failure of Heparin Thromboprophylaxis in a Patient with Acute Traumatic Spinal Cord Injury
Model of Spyropoulos et al for Identifying a Hospitalized Medical Patient at Risk for Venous Thromboembolism on Admission
IMPACTILL Model of Spyropoulos et al for Identifying a Hospitalized Medical Patient at Risk for Venous Thromboembolism
American College of Physicians (ACP) Guidelines for Venous Thromboembolism (VTE) Prophylaxis in a Hospitalized Medical Patient
Risk Factors of Mantilla et al for Clinical Relevant Thromboemboli in a Patient Undergoing Knee or Hip Arthroplasty
Risk Factors of Scarborough et al for Venous Thromboembolism Following Aortic Surgery
Clinical Features of Superficial Thrombophlebitis and Superficial Migratory Thrombophlebitis
Paradoxical Thrombosis
Classification of Simonneau et al for Anticoagulation-related Bleeding
Risk Score of Landefeld et al for Anticoagulant-related Major Bleeding in Hospitalized Patients
Utrecht Bleeding Risk Score During Treatment of Acute Venous Thromboembolism
Risk Factors for Bleeding During Warfarin Therapy
Risk Score of Kuijer et al for Bleeding During Anticoagulant Treatment for Venous Thromboembolism
Contraindications to Anticoagulant Therapy
Bleeding Risk Indices of van der Meer et al
Risk Score of Landefeld and Goldman for Warfarin-Associated Major Bleeding in Outpatients
The Bleeding Severity Index of Landefeld et al for Bleeding Caused by Medical Therapy
Risk Factors of Walker and Jick for Bleeding During Heparin Therapy
Clinical Features of a Retroperitoneal Hematoma in an Anticoagulated Patient
Risk Factors of Alexander et al for an Excessive Dose of a Glycoprotein IIb/IIIa Inhibitor with Bleeding During the Treatment of Non-ST Segment Elevation Acute Coronary Event
Criteria of Graafsma et al for Anticoagulant-Related Bleeding with a Bleeding Severity Index
The Outpatient Bleeding Risk Index of Beyth et al
Criteria of Montalescot et al for Major and Minor Bleeding During Heparin Therapy (STEEPLE Criteria)
Bleeding Risk Model of Shireman et al for an Elderly Patient Being Treated with Warfarin
BleedScore of Serebruany and Atar for Classifying Bleeding Events
Risk Score of Mehran et al for Bleeding in a Patient Receiving Antithrombotic Therapy for the Acute Coronary Syndrome (ACS)
CRUSADE Bleeding Score for Predicting Major In-Hospital Bleeding in a Patient Being Treated for Non-ST-Segment Elevation Myocardial Infarction
Risk Factors of Manoukian et al for Major Bleeding in a Patient with an Acute Coronary Syndrome in the ACUITY Trial
HAS-BLED Score for Predicting the Risk of Major Bleeding in a Patient with Atrial Fibrillation
HEMORR2HAGES Score of Gage et al for Predicting Hemorrhage in a Patient with Atrial Fibrillation
Risk Factors for Bleeding During Antithrombotic Therapy from the NICE Guidelines for Atrial Fibrillation
Risk Score of Ducrocq et al for Serious Bleeding in a Patient at Risk for Atherothrombosis (REACH Score)
Evaluating a Patient for Abnormal Bleeding from an Occult Malignancy Associated with Anticoagulant or Antithrombotic Therapy
Bleeding Academic Research Consortium (BARC) Classification of Bleeding
Antithrombin III Replacement Therapy
Indications for Measuring Antithrombin III Levels
Predicting Survival in Thrombotic Thrombocytopenia Purpura with Laboratory Tests
Clinical Severity Scoring System of Rose and Eldor for TTP or HUS
Prognostic Factors of Pereira et al in Thrombotic Thrombocytopenic Purpura and the Hemolytic Uremic Syndrome
Deficiency in ADAMTS13 and Thrombotic Thrombocytopenic Purpura
Recurrent or Familial Hemolytic-Uremic Syndrome or Membranoproliferative Glomerulonephritis in Factor H Deficiency
Criteria of Tuncer et al for Clinical Outcome After Treating a Patient with TTP-HUS
Modified Rose Index of the Canadian Apheresis Group for TTP or HUS
Index of Wyllie et al for Predicting Mortality in a Patient with TTP or HUS
Risk Factors of Oakes et al for Mortality in a Pediatric Patient with Postdiarrheal Hemolytic Uremic Syndrome
HIV-Related Thrombotic Thrombocytopenic Purpura (TTP) and Hemolytic Uremic Syndrome (HUS)
Clinical Features of the Atypical Hemolytic-Uremic Syndrome
Criteria of Zhan et al for Therapeutic Response in a Patient with Thrombotic Thrombocytopenic Purpura (TTP)
Conditions Associated with Thrombotic Thrombocytopenic Purpura (TTP)
Use of the Platelet Count and Prothrombin Time to Separate TTP-HUS from DIC
Clinical Prediction Score of Bentley et al for Thrombotic Thrombocytopenia Purpura (TTP)
Classification and Regression Tree (CART) of Bentley et al to Identify a Patient with Low ADAMTS13
Algorithm of Caramazza et al for Management of a Patient with TTP-HUS
Congenital Thrombotic Thrombocytopenic Purpura (TTP)
Clinical Features of Upshaw-Schulman Syndrome (USS)
Initial Evaluation of a Patient with Thrombotic Thrombocytopenic Purpura (TTP)
Neonatal Hemolytic Uremic Syndrome (HUS) Associated with Cobalamin C Disease
Hemolytic Uremic Syndrome (HUS) in Children Associated with Invasive Streptococcus pneumoniae (Streptococcus pneumoniae-Associated Hemolytic Uremic Syndrome, SP-HUS)
Risk Factors of Peigne et al for Death in a Patient with a Thrombotic Microangiopathy
Laboratory Diagnosis of Antiphospholipid Syndromes
Clinical Syndromes Associated with Anticardiolipin Antibodies
Evaluation of a Patient with a Lupus Anticoagulant and a Prolonged Prothrombin Time (Hypoprothrombinemia-Lupus Anticoagulant Syndrome)
Catastrophic Antiphospholipid Syndrome (CAP, Asherson Syndrome)
Features of Antiphospholipid Antibody-Associated Cardiac Valve Disease
Features of Antiphospholipid Antibody-Associated Nephropathy
Features of Antiphospholipid Antibody-Associated Livedo Reticularis
Features of Antiphospholipid Antibody-Associated Thrombocytopenia
Sneddon Syndrome (Livedo Reticularis and Ischemic Cerebrovascular Disease) Associated with Antiphospholipid Antibodies
Updated International Consensus Criteria for the Diagnosis of the Antiphospholipid Syndrome (Sydney Criteria)
Risk Factors of Tarr et al for Thrombosis in a Lupus Patient with Antiphospholipid Antibodies
Reasons to Suspect the Antiphospholipid Antibody Syndrome in a Patient with a Disorder Resembling Multiple Sclerosis (MS)
Score of Goel et al for Familial Antiphospholipid Antibody Syndrome: Clinical Subscore
Score of Goel et al for Familial Antiphospholipid Antibody Syndrome: Laboratory Subscores
Score of Goel et al for Familial Antiphospholipid Antibody Syndrome: Evaluation of the Patient and Family
Risk Factors for Thrombosis in a Patient with Systemic Lupus Erythematosus (SLE)
Lupus Anticoagulant-Hypoprothrombinemia Syndrome (LAHPS)
Criteria of Asherson et al for the Catastrophic Antiphospholipid Syndrome (CAPS)
Lupus Anticoagulant Sensitivity Index (LASI)
Conditions Associated with the Lupus Anticoagulant
Sticky Platelet Syndrome
Indications to Evaluate a Patient for Hypercoagulability (Thrombophilia)
Heparin-Induced Thrombocytopenia Types I and II
Score of Pouplard et al for Estimating the Likelihood of Heparin-Induced Thrombocytopenia
Testing Algorithm for the Diagnosis of Heparin-Induced Thrombocytopenia
Therapy for Heparin-Induced Thrombocytopenia with Lepirudin (Refludan) in a Patient with Normal Renal Function
Therapy for Heparin-Induced Thrombocytopenia with Lepirudin (Refludan) in a Patient with Renal Insufficiency
Scoring System of Chong and Chong for Diagnosis of Heparin-Induced Thrombocytopenia (HIT)
Acute Systemic Reaction Following Administration of Intravenous Heparin
Conditions That May Mimic Heparin-Induced Thrombocytopenia (Pseudo-HIT)
Score of Warkentin and Heddle for the Diagnosis of Heparin-Induced Thrombocytopenia (HIT)
White Clot Syndrome in Heparin-Induced Thrombocytopenia (HIT)
Skin Lesions at Subcutaneous Heparin Injection Sites in a Patient with Heparin-Induced Thrombocytopenia (HIT)
Acute Adrenal Hemorrhage in a Patient with Heparin-Induced Thrombocytopenia (HIT)
Delayed-Onset Heparin-Induced Thrombocytopenia
Risk Factors of Elalamy et al for an Unfavorable Clinical Outcome in Patients with Heparin-Induced Thrombocytopenia (HIT)
Simple Scoring System of Messmore et al for Early Management of Heparin-Induced Thrombocytopenia (HIT)
DIC Score of Bick
Monitoring Therapy for DIC with the DIC Score
DIC Score of Yu et al
DIC Scoring Algorithm of the ISTH Scientific and Standardization Committee
Kasabach-Merritt Phenomenon and Vascular Tumors in Children
Risk Factors for Disseminated Intravascular Coagulation (DIC) in a Trauma Patients
Criteria of the ISTH Scientific and Standardization Committee for Non-Overt DIC
The New Japanese Diagnostic Criteria for Disseminated Intravascular Coagulation in Critically Ill Patients (Japanese Association of Acute Medicine or JAAM Criteria)
Criteria of Shirahata et al for Disseminated Intravascular Coagulation (DIC) in a Newborn Infant
Criteria of Kobayashi et al for Disseminated Intravascular Coagulation (Japanese Diagnostic Criteria, Japanese Ministry of Health and Welfare, JMHW)
Classification of Disseminated Intravascular Coagulation (DIC) Based on the Degree of Compensation in the Production of Coagulation Factors and Platelets
Evolving DIC Score of Kinasewitz et al in a Septic Patient
Consumptive Coagulopathy in a Patient with a Large Venous Malformation
Contraindications to Thrombolytic Therapy
Bleeding Risk after Contemporary Thrombolytic Therapy Following Myocardial Infarction
Thrombolytic Predictive Instrument of Selker et al for Intracranial Hemorrhage
Thrombolytic Predictive Instrument of Selker et al for Major Bleeding
Dosing an Infusion of Abbokinase Brand Urokinase for a Patient with Pulmonary Embolism
Determining the Dose of Alteplase for Thrombolysis in Acute Stroke
Determining the Accelerated Infusion Dose of Alteplase for Thrombolysis in Acute Myocardial Infarction
Determining the Dose of Alteplase for a 3 Hour Infusion After Acute Myocardial Infarction
Model of Sloan et al for Risk of 30-Day Mortality Associated with Intracranial Hemorrhage Associated with Thrombolysis Therapy After Acute Myocardial Infarction
Contraindications (Exclusion Criteria) of Wechsler for Intravenous Tissue Plasminogen Activator (t-PA) Therapy Following Acute Ischemic Stroke
Guidelines of Thomson et al for Anticoagulant Therapy to Prevent Stroke in Patients with Atrial Fibrillation
Prophylactic Therapy to Reduce the Risk of Stroke in Patients with Atrial Fibrillation
Algorithm of Hardman and Cowie for Anticoagulation Therapy in Non-Rheumatic Atrial Fibrillation
Rule of van Walraven et al for Using Aspirin as Stroke Prophylaxis in Patients with Non-Valvular Atrial Fibrillation
Clinical Staging of Immune Thrombocytopenic Purpura
Classification of Holt for the Response to Therapy in a Child with Immune Thrombocytopenic Purpura (ITP)
Risk Factors of Schattner and Bussel for Mortality in Immune Thrombocytopenic Purpura (ITP)
Criteria of Stasi et al for Response to Therapy for Immune Thrombocytopenic Purpura (ITP)
Criteria of Blanchette et al for Bleeding Severity in a Child with Acute Idiopathic Thrombocytopenic Purpura (ITP)
Criteria of Bolton-Maggs and Moon for Bleeding Severity in a Child with Acute Idiopathic Thrombocytopenic Purpura (ITP)
Grading Criteria of Buchanan and Adix for Hemorrhage in a Child with Acute Idiopathic Thrombocytopenic Purpura (ITP)
Criteria of Medeiros and Buchanan for Major Hemorrhage in a Child with Acute Idiopathic Thrombocytopenic Purpura (ITP)
Outcomes of Portielje et al for an Adult with Idiopathic Thrombocytopenic Purpura
Criteria of Lacey and Penner for Idiopathic Thrombocytopenic Purpura (ITP) in the Adult
Bleeding Score of Godeau et al for a Patient with Autoimmune Thrombocytopenic Purpura
Bleeding Score of Khellaf et al for a Patient with Autoimmune Thrombocytopenic Purpura
Recommendations of Stasi and Provan for Emergency Treatment of a Patient wtih Immune Thrombocytopenic Purpura
Immune Thrombocytopenia Associated with Helicobacter pylori Gastritis
The Post-Thrombotic Score (PTS) of Brandjes et al
The Post-Thrombotic Score (PTS) of Villalta et al
Criteria of Goldenberg et al for the Post-Thrombotic Syndrome in a Child
Clinical Features of Upper Extremity Post-Thrombotic Syndrome
Criteria for Superwarfarin-induced Coagulopathy
Factitious Bleeding Disorder Associated with Self-Administration of Warfarin
Criteria for Acquired von Willebrand's Disease
Types of von Willebrand's Disease Based on Laboratory Test Findings
Criteria of the Hospital for Sick Children for Significant Mucocutaneous Bleeding in a Patient with von Willebrand's Disease
Criteria of the International Society on Thrombosis and Haemostasis (ISTH) for Significant Mucocutaneous Bleeding in a Patient with von Willebrand's Disease
Desmopressin Test Dose in a Patient with von Willebrand's Disease
Bleeding Score of Tosetto et al for a Patient with von Willebrand's Disease
Acquired von Willebrand's Disease with Bleeding in a Patient with Essential Thrombocythemia
Classification of Michiels et al for Acquired von Willebrand Syndrome (AvWS)
Pseudo von Willebrand Disease (Platelet Type or PT von Willebrand Disease)
Evaluation of PT and aPTT Test Results
Using Factor V and VII Levels in the Evaluation of the Bleeding Patient
Correction of the Whole Blood Fibrinogen for Hematocrit and Correlation with Plasma Fibrinogen
Use of Vitamin K to Reverse Warfarin-Associated Coagulopathy
Use of Prothrombin Complex Concentrate to Reverse the Effects of a Vitamin K Antagonist
Use of Fresh Frozen Plasma (FFP) to Reverse the Effects of a Vitamin K Antagonist
Protocol of Goodnough et al for Reversal of a Prolonged INR with Recombinant Factor VIIa (rFVIIa)
Therapeutic Options for a Patient with Uremic Bleeding
Clinical Features of Uremic Bleeding
Bleeding Risk Index of Elting et al in Patients with Malignant Lymphoma or Solid Tumors
Deep Vein Thrombosis Associated with Carcinoma (Trousseau's Syndrome)
Risk Factors of Blom et al for Venous Thrombosis in a Patient with a Malignancy
Risk Factors of Khorana et al for Venous Thromboembolism in a Patient with Cancer Starting Chemotherapy
Risk Factors of Khorana et al for Thromboembolism in a Hospitalized Cancer Patient with Neutropenia
Algorithm of Gerber et al for Managing a Patient with Venous Thromboembolism and a Primary or Metastatic Brain Tumor
Risk Factors of Bohlius et al for Thrombosis Associated with Recombinant Human Erythropoietin Therapy in a Patient with Cancer
Risk Factors of Chew et al for Venous Thromboembolism in a Woman with Breast Cancer
Risk Factors of Tesselaar and Osanto for Venous Thromboembolism in a Patient with Lung Cancer
Risk Score of Kim et al for Fatal Intracranial Hemorrhage in a Patient with Acute Leukemia
Risk Factors of Lyman et al for Venous Thromboembolism in a Patient with a Malignant Disease
Acquired von Willebrand's Syndrome (AVWS) in a Child with Wilm's Tumor
Risk Score of Khorana et al for Chemotherapy-Associated Thrombosis
Risk Score of Ay et al for Venous Thromboembolism in a Patient with Cancer (Expanded Khorana Score)
Soluble P-Selectin and Other Risk Factors of Ay et al for Venous Thromboembolism in a Patient with Cancer
Risk Factors for Thromboembolism in a Patient with Multiple Myeloma
Risk Factors of Anaissie et al for Venous Thromboembolism in a Patient with Multiple Myeloma
Risk Factors of Yokoyama et al for Venous Thromboembolism in a Japanese Patient with Diffuse Large B-Cell Lymphoma
Bleeding Severity Measurement Scale (BSMS) of Webert et al for a Patient with Chemotherapy-Induced Thrombocytopenia
Contraindications to the Use of Recombinant Protein C
Algorithm of Cunningham et al for Laboratory Testing in a Patient with Suspected Dysfibrinogenemia
Clinical and Laboratory Features of Congenital Afibrinogenemia or Hypofibrinogenemia
Clinical and Laboratory Features of Congenital Dysfibrinogenemia
Clinical and Laboratory Features of Fibrinogen Brescia (Familial Hypofibrinogenemia with Hepatocytic Inclusion Bodies)
Classification of Medicina et al for Hereditary Disorders of Fibrinogen Associated with Hepatocytic Inclusion Bodies
Risk Factors of Oh et al for Early and Late Hepatic Artery Thrombosis After Liver Transplantation
Risk Factors of Vivarelli et al for Hepatic Artery Thrombosis or Stenosis After Liver Transplantation
Aspirin Resistance
Contraindications to Aspirin Therapy
Recommendations of the French Society of Anesthesiology and Intensive Care (SFAR) for Administration of Antiplatelet Agents in the Perioperative Period
Treatment of a Bleeding Patient with Liver Failure
Hemostatic Defects in a Patient with End-Stage Liver Disease
Protocol of Poetzsch and Madlener for Anticoagulation During Cardiopulmonary Bypass Using Danaparoid Sodium
Protocol of Poetzsch and Madlener for Anticoagulation During Cardiopulmonary Bypass Using Lepirudin (r-Hirudin)
Reversal of Unfractionated Heparin Therapy with Protamine Sulfate
Patients to Screen for Allergy to Protamine Sulfate
Types of Adverse Reactions Following Administration of Protamine Sulfate
Reversal of Dalteparin Sodium Overdosage with Protamine Sulfate
Protocol of Hirsh and Raschke for the Reversal of Antithrombotic Effect of Low Molecular Weight Heparin (LMWH) Using Protamine Sulfate
Protocol of Cole et al for Use of Aprotinin in Children Undergoing Spinal Surgery
Prophylactic Dosage Regimens of Dalteparin Sodium for Hip Replacement Surgery
Antenatal Thromboembolic Prophylaxis with Low Molecular Weight (LMW) Heparin
Dosing Low Molecular Weight (LMW) Heparin for the Treatment of Venous Thromboembolism in Early Pregnancy
Weight-Based Dosing Equation of Rondina et al for Thromboprophylaxis in a Morbidly Obese Patient
Risk Factors of DeVeber et al for Cerebral Sinovenous Thrombosis in Children
Clinical Findings in a Patient with a Cerebral Sinus Thrombosis
Risk Factors of Starn for Thrombosis of a Cerebral Vein or Sinus
Risk Factors of Hanes et al for Thrombocytopenia in a Trauma Patient in the Intensive Care Unit (ICU)
Risk Factors of Ferrara et al for Coagulopathy and Death Following Massive Transfusion for Trauma
Criteria of Talving et al for Coagulopathy Associated with Traumatic Brain Injury (TBI)
Risk Factors of Talving et al for Traumatic Brain Injury (TBI) Associated Coagulopathy
Conditions Associated with Systemic Fibrinolysis
Features of a Hereditary Deficiency of Alpha-2 Antiplasmin
Plasminogen Activator Inhibitor (PAI) Concentration and Genotype
Congenital Plasminogen Deficiency Type I with Ligneous Conjunctivitis
Effects on Coagulation Associated with Herbal or Dietary Supplements
Inhibitory Effect of Chocolate and Cocoa on Platelet Aggregation
Foods Rich in Polyphenols and Flavonoids
Thrombosis Risk Associated with Intravenous Immune Globulin Therapy
Models of Holland and Brooks for Predicting the Impact of Fresh Frozen Plasma (FFP) Transfusion on the INR
Calculating Amount of Factor Replacement
Increment in Coagulation Factor after Transfusion
Factor VIII-vWF Dosage Recommendations of Mannucci for a Patient with von Willebrand's Disease
Estimating the Peak Factor VIII Coagulant Activity Needed When Treating a Patient with von Willebrand's Disease
Therapy with Recombinant Factor VIIa in a Patient with a Factor VIII or IX Inhibitor
Risk Factors Associated with Thrombosis Following Recombinant Factor VIIa Therapy
Use of Recombinant Factor VIIa in a Patient with Congenital Factor VII Deficiency
Therapy with Recombinant Factor VIIa for Uncontrollable Hemorrhage in a Patient with a Qualitative or Quantitative Platelet Disorder
Therapy with Recombinant Factor VIIa for Uncontrollable Hemorrhage in a Patient with Liver Disease, Trauma or Recent Surgery
Therapy with Recombinant Factor VIIa for Control of Massive Pulmonary Hemorrhage
Factors of Knudson et al Associated with Poor Response to Recombinant Factor VIIa in a Trauma Patient
Criteria of George et al for the Diagnosis of Drug-Induced Thrombocytopenia
Algorithm of Berkowitz et al for Thrombocytopenia Following Infusion of Abciximab (c7E3 Fab)
Differential Diagnosis of Thrombocytopenia in an HIV-Positive Patient
Screening Tool of Philipp et al for a Bleeding Disorder in a Woman with Menorrhagia
Criteria of Federle et al for Distinguishing Abdominal Bleeding Due to Coagulopathy from a Ruptured Abdominal Aortic Aneurysm on CT Scan
Differential Diagnosis of Bleeding in a Patient with Normal PT and aPTT
Ovarian Bleeding in a Woman with a Congenital Bleeding Disorder
Heparin-Related Bleeding in a Patient with a Mast Cell Disorder
Risk Factors for Epinephrine Intoxication Following Injection or Topical Application
Clinical Findings of Epinephrine Intoxication Following Injection or Topical Application As a Hemostatic Agent
Causes of Spontaneous Retroperitoneal Hemorrhage
Lenk's Triad and Other Signs and Symptoms of Spontaneous Retroperitoneal Hemorrhage
Wunderlich's Syndrome (Spontaneous Retroperitoneal Hemorrhage From One or Both Kidneys)
Clinical and Laboratory Features of Neonatal Isoimmune Thrombocytopenia
Clinical Features of Hemorrhagic Disease of the Newborn (HDNB)
Risk Factors for Vitamin K Deficiency Bleeding (VKDB) in an Infant
Classification of Hemorrhagic Disease of the Newborn (HDNB) Based on Time of Clinical Onset
Differential Diagnosis of Hemorrhagic Disease of the Newborn (HDNB)
Intravenous Therapy with Tranexamic Acid in Severe Trauma
Use of RICE as Adjunctive Management of Hemorrhage in a Patient with Hemophilia
Factors Affecting the Safety of Prophylactic Anticoagulant Therapy of a Patient at Risk for Venous Thromboembolism
Peds-Clot Clinical Decision Rule of Sharathkumar et al
Score of Kucher et al for the Risk of Venous Thrombembolism (VTE) in a Hospitalized Patient
Padua Prediction Score (PPS) for Risk of Venous Thrombembolism (VTE) in a Hospitalized Patient
Caprini Risk Model for Venous Thromboembolism
Risk Factors of Doepker et al for Bleeding in a Patient in the ICU Anticoagulated with Argatroban
Hypercoagulability in Patient with Thalassemia
Dosing Argatroban for a Patient with Heparin-Induced Thrombocytopenia (HIT)
Equations of Schlimp et al for Predicting Plasma Fibrinogen in the Emergency Room Following Major Trauma
Algorithm of Stern et al for Anticoagulating a Patient with Chronic Atrial Fibrillation
Flowchart of Lip et al for Using an Oral Anticoagulant to Prevent Stroke in a Patient with Atrial Fibrillation
Predictors of Hart et al for Ischemic Stroke in a Patient Receiving Aspirin Therapy for Atrial Fibrillation
Risk Factors of Galanaud et al for Post-Thrombotic Syndrome (PTS) Following a First Episode of Deep Vein Thrombosis
Acquired von Willebrand's Disease Associated with High Wall Shear Flow Rates
Risk Factors of Ahlbrecht et al for Venous Thromboembolism in a Patient with Cancer
Risk Factors of Caruso et al for Thromboembolism in Children with Acute Lymphoblastic Leukemia (ALL)
International Prognostic Score of Thrombosis in Essential Thrombocythemia (IPSET-thrombosis) of Barbui et al
Risk Factors of Cosgriff et al for Severe Coagulopathy in a Trauma Patient Who Has Been Massively Transfused
Data on Coagulation Factors
Using Thromboelastography to Guide the Management of a Bleeding Patient
Criteria of Kashuk et al for Hypercoagulability in a Postoperative Patient Using Rapid Thromboelastography
Recommendations of Stasi and Provan for Managing a Patient with Immune Thrombocytopenic Purpura
Risk Score of Atchison et al Hospital-Associated Venous Thromboembolism in a Noncritically-Ill Pediatric Patient
Risk of Deep Vein Thrombosis and Pulmonary Embolism in Chinese Patients with Sjogren?s Syndrome
Indications for Testing a Patient for the Factor V HR2 Haplotype
Model of Iannuzzi et al for Predicting Postdischarge Venous Thromboembolism
Model of Ruiz-Gimenez et al for Major Bleeding in a Patient Receiving Anticoagulation for an Acute Venous Thromboembolism (RIETE Score)
Antiphospholipid Score of Otomo et al
Indications of Lahey et al for a Laboratory Evaluation for Hypercoagulation for a Patient with Central Retinal Vein Occlusion (CRVO)
Score of Sivula et al for Disseminated Intravascular Coagulation (DIC) in the a Critically-Ill Patient
Predictors of Hagemo et al for Hypofibrinogenemia in an Adult Trauma Patient
Acquired Glanzmann?s Thrombasthenia
Differential Diagnosis of Thrombocytopenia in the Intensive Care Unit (ICU)
Clinical Prediction Score of Constans et al for Upper Extremity Deep Vein Thrombosis (UEDVT)
Clinical Prediction Score of Constans et al for Lower Limb Deep Vein Thrombosis in a Symptomatic Hospitalized Patient (Saint-Andre Hospital Score)
NAVAL Score of de Bastos et al for Predicting the Risk of Hospital-Acquired Venous Thrombosis
Indications of Hill et al to Screen a Patient with Thrombosis for Paroxysmal Nocturnal Hemoglobinuria (PNH)
Clinical Features of Thrombosis in Paroxysmal Nocturnal Hemoglobinuria (PNH)
Indications of Hall et al for Prophylactic Anticoagulation in a Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH)
Prognostic Score of Trujillo-Santos et al for an Outpatient with Acute Deep Vein Thrombosis (DVT) in the Lower Extremity
Prognostic Score of Rosa-Salazar et al for an Outpatient with Acute Deep Vein Thrombosis (DVT) in the Upper Extremity
Predictive Score of Nieto et al for Fatal Bleeding During Anticoagulant Therapy for Venous Thromboembolism
Decision Tree of Hong et al for a Patient with Microangiopathic Hemolytic Anemia and Possible Thrombotic Thrombocytopenic Purpura
Thrombotic Thrombocytopenic Purpura (TTP) Following Exposure to Amphetamine, Methamphetamine or Ecstasy
Thrombotic Thrombocytopenic Purpura (TTP) Associated with Thienopyridine (Clopidogrel, Prasugrel, Ticlopidine) Therapy
Pseudo-Thrombotic Thrombocytopenic Purpura (Pseudo-TTP) in a Patient with Vitamin B12 Deficiency (Pseudo-Thrombotic Microangiopathy)
The Global Anti-Phospholipid Syndrome Score (GAPSS) of Sciascia et al
Criteria of Asakura for the Enhanced Fibrinolytic Type of Disseminated Intravascular Coagulation (DIC)
Intensive Care After Thrombolysis (ICAT) Score of Faigle et al for a Patient with Stroke
SEDAN Score of Strbian et al for Predicting Symptomatic Intracranial Hemorrhage after Stroke Thrombolysis
Hemorrhage After Thrombolysis (HAT) Score of Lou et al for Predicting the Risk of Intracerebral Hemorrhage (ICH) in a Patient with Ischemic Stroke
GRASPS Score of Menon et al for Predicting Symptomatic Intracranial Hemorrhage after Stroke Thrombolysis
Risk Score of Cucchiara et al for Predicting the Risk of Intracerebral Hemorrhage (ICH) in a Patient with Ischemic Stroke
Stroke Prognostication Using Age and NIHSS (SPAN) Index for a Patient Undergoing Intravenous Thrombolysis for Ischemic Stroke
DIC, Thrombosis and Thrombohemorrhage in Acute Promyelocytic Leukemia (APML)
HERDOO2 Score of Rodger et al for Discontinuing Oral Anticoagulant Therapy in a Woman with an Unprovoked Venous Thromboemolism
Deep Vein Thrombosis (DVT) Associated with May-Thurner Syndrome (MTS, Iliac Vein Compression)
I-DVT and Adjusted I-DVT Scores of Dronkers et al for a Patient with Acute Deep Vein Thrombosis
ORBIT Bleeding Score of O'Brien et al for Bleeding Risk in Atrial Fibrillation
ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Score of Fang et al
Risk Factors of Kearon et al for Warfarin-Associated Hemorrhage
Age, Biomarkers, Clinical History (ABC) Bleeding Risk Score of Hijazi et al for a Patient with Atrial Fibrillation
Plasmic Score of Bendapudi et al for Identifying a Patient with Thrombotic Thrombocytopenic Purpura (TTP)
Algorithm of Williams et al for the Diagnosis of Microangiopathic Hemolytic Anemia (MAHA) Associated with Thrombocytopenic Purpura (TTP) or Atypical Hemolytic Uremic Syndrome (AHUS)
Algorithm of Williams et al for the Diagnosis of Microangiopathic Anemia (MAHA) Associated with Typical Hemolytic Uremic Syndrome (HUS)
Mortality in TTP Score (MITS) of Goel et al for a Patient with Thrombotic Thrombocytopenic Purpura (TTP)
Hypercoagulability Associated with Hereditary Stomatocytosis
Safe Implementation of Treatments in Stroke (SITS) Symptomatic Intracerebral Hemorrhage Risk Score of Mazya et al
Revised IPSET-Thrombosis (International Prognosis Score of Thrombosis for Essential Thrombocythemia - Thrombosis) of Barbui et al
Score of Koopman et al for Predicting Outcome for a Patient with Cerebral Venous Thrombosis (CVT)
Score of Ferro et al for Predicting Outcome for a Patient with Cerebral Vein and Dural Sinus Thrombosis
Platelet Count and the Prognosis of a Patient in the Intensive Care Unit (ICU)
Risk Factors of Wang et al for Venous Thromboembolism in a Patient Undergoing Spine Surgery
Venous Thrombosis in a Patient with Sickle Cell Disease
Acquired Risk Factors of Pannucci et al for Venous Thromboembolism After Thermal Burn Injury
Score of Pannucci et al for Risk of Venous Thromboembolism in a Burn Patient on Admission
Risk Score of Pannucci et al for Venous Thromboembolism Following Ventral Hernia Repair
Risk Score of Pannucci et al for 90-Day Postsurgical Venous Thromboembolism
TIMI-AF Score of Fanola et al for Predicting Risk of an Adverse Event in a Patient with Atrial Fibrillation
Coagulapathy of Severe Trauma (COAST) Score of Mitra et al
Prehospital Prediction Model for Acute Traumatic Coagulopathy (PACT) of Peltan et al
Thrombosis in a Patient with Eosinophilia
I-DVT Score of Dronkers et al for the Diagnosis of Acute Deep Vein Thrombosis (DVT)
Risk Factors of Baelum et al for Venous Thromboembolism (VTE) in a Patient with Thrombocytopenia
Score of Sermsathanasawadi et al for the Diagnosis of Lower Limb Deep Vein Thrombosis (DVT)
Criteria of Rast et al for Differentiating Deep Vein Thrombosis from Lower Limb Erysipelas in the Lower Limb
Risk Factors of Sivaslioglu et al for Thrombosis in Pediatric Patients with Acute Lymphoblastic Leukemia (ALL)
Clinical Score of Pomero et al for the Diagnosis of Deep Vein Thrombosis in a Patient with Superficial Vein Thrombosis (ICARO Score)
Risk Factors of Alkim et al for Deep Vein Thrombosis in a Patient with Inflammatory Bowel Disease (IBD)
Drug-Induced Venous Thromboembolism (VTE)
Neurological Syndrome Associated with Shiga-Toxin Producing E. coli (STEC) with Hemolytic Uremia Syndrome (Neuro-STEC)
Score of Rose et al for Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome (TTP/HUS)
Model of Benhamou et al for Predicting Mortality in a Patient with Acquired ADAMTS13-Deficient Idiopathic Thrombotic Thrombocytopenia Purpura (TTP)
Score of Coppo et al for Severe Acquired ADAMTS12 Deficiency and Thrombotic Microangiopathy (TMA, French TMA Diagnostic Score)
Complete Response, Relapse and Flare-Up of a Thrombotic Thrombocytopenic Purpura (TTP)
Criteria of the Korean Society for Thrombosis and Hemostasis (KSTH) for Overt DIC
Revised Japanese Association of Acute Medicine (R-JAAM) Score for Disseminated Intravascular Coagulation (DIC)
Criteria of the Japanese Society of Thrombosis and Hemostasis (JSTH) for Disseminated Intravascular Coagulation (DIC): Initial Triage
Criteria of the Japanese Society of Thrombosis and Hemostasis (JSTH) for Disseminated Intravascular Coagulation (DIC): Hematopoietic Disorder
Criteria of the Japanese Society of Thrombosis and Hemostasis (JSTH) for Disseminated Intravascular Coagulation (DIC): Infectious Disease
Criteria of the Japanese Society of Thrombosis and Hemostasis (JSTH) for Disseminated Intravascular Coagulation (DIC): Basic Type
Conditions Associated with Disseminated Intravascular Coagulation (DIC)
Modified ISTH Criteria of Clark for Disseminated Intravascular Coagulation (DIC During Pregnancy
Immune Thrombocytopenic Purpura (ITP) Bleeding Scale (IBLS) of Page et al
Risk Factors of Melboucy-Belkhir et al for Intracranial Hemorrhage in a Patient with Immune Thrombocytopenic Purpura (ITP)
Risk Factors of Webert et al for Bleeding in a Thrombocytopenic Patient with Acute Myeloid Leukemia (AML)
INR-Based Criteria of Peltan et al for Acute Traumatic Coagulopathy
4-Group Classification of Kawashima et al for Postoperative Bleeding After Cardiopulmonary Bypass Based on Fibrinogen and ROTEM (Fuji-san Classification)
IMPROVE Bleeding Risk Score for an Inpatient on a Medical Service
Azathioprine-Associated and 6-Mercaptuopruine-Associated Warfarin Resistance
Risk Factors of Kim et al for Venous Thromboembolism (VTE) in a Patient with Chronic Obstructive Pulmonary Disease (COPD)
Risk Factors of Chopra et al for Deep Vein Thrombosis Associated with a Peripherally-Inserted Central Catheter (PICC)
Risk Factors of Emuakhagbon et al for Deep Vein Thrombosis Following Liver Transplantation
Risk Factors of Faller et al for Mortality in an Older Adult with Acute Venous Thromboembolism
Risk Factors of Michetti et al for Deep Vein Thrombosis (DVT) During Acute Inpatient Rehabilitation Following Trauma
Risk Factors for Deep Vein Thrombosis Following Splenectomy
Risk Factors of Johnseon et al for Venous Thromboembolism in a Patient with System Sclerosis (Scleroderma)
Differential Diagnosis of Recurrent Deep Vein Thrombosis (DVT)
Diagnostic Approach of Trachil for Recurrent Deep Vein Thrombosis (DVT)
Splanchnic Vein Thrombosis
Renal Vein Thrombosis
Ovarian Vein Thrombosis
Atypical Hemolytic Uremic Syndrome (HUS) Associated with Factor H Autoantibodies (DEAP-HUS)
Hypercoagulability Associated with Cushing's Syndrome
Differential Diagnosis of Kobayashi Obstetrical Disseminated Intravascular Coagulation (DIC)
Obstetrical Disseminated Intravascular Coagulation (DIC) Score of Kobayashi: Underlying Disease Subscore
Obstetrical Disseminated Intravascular Coagulation (DIC) Score of Kobayashi: Subscore for Clinical Symptoms
Obstetrical Disseminated Intravascular Coagulation (DIC) Score of Kobayashi: Laboratory Subscore
Obstetrical Disseminated Intravascular Coagulation (DIC) Score of Kobayashi: Summary Score
Obstetrical Disseminated Intravascular Coagulation (DIC) Efficacy Score of Kobayashi: Laboratory Subscore
Obstetrical Disseminated Intravascular Coagulation (DIC) Efficacy Score of Kobayashi
Hazards of Nonsteroidal Anti-Inflammatory Drugs (NSAIDS) for a Patient Taking an Oral Anticoagulant for Atrial Fibrillation
Secondary Causes of Immune Thrombocytopenic Purpura (ITP)
Risk Factors of Andriani et al for Thrombosis in a Patient with Essential Thrombocythemia
Nomogram of Pabinger et al for Predicting Venous Thromboembolism in a Patient with Cancer
Risk Factors of Ihaddadene for Occult Malignancy in a Patient with a First Unprovoked Venous Thromboembolism (VTE)
COMPASS Cancer-Associated Thrombosis (CAT) Score of Gerotziafas et al
Coagulopathy Following Hepatic Resection
Trauma Induced Coagulopathy Clinical Score (TICCS) of Tonglet et al
Risk Factors of Lim et al for Failure of Anticoagulant Thromboprophylaxis in ICU Patients
Score of Pannucci et al for Predicting the Risk of Venous Thromboembolism After Outpatient Surgery
Score of Finks et al for Venous Thromboembolism After Bariatric Surgery
Predictors of Wakabayashi et al for the Presence of Deep Vein Thrombosis (DVT) in a Patient Prior to Total Hip Arthroplasty
Risk Factors of Wang for Venous Thromboembolism in a Hospitalized Patient Receiving Thromboprophylaxis
Criteria of Kelkar et al for Synthetic Cannabinoid-Associated Coagulopathy
Laboratory Detection of Poisoning with a Coumarin or Indandione Compound (Vitamin K Antagonist)
Protecht Score of Verso et al for Risk of Venous Thromboembolism in a Cancer Patient
CONKO Score of Pelzer et al for Risk of Venous Thromboembolism in a Cancer Patient
Differential Diagnosis of Hypofibrinogenemia
Prehospital Predictors of David et al for Coagulopathy in a Trauma Patient
Differential Diagnosis of Elevated Fibrin Degradation Products (D-Dimer, Fibrin Split Products)
Idarucizumab (Praxbind) for Reversal of Dabigatran (Pradaxa)
Andexanet Alfa (Andexxa) for Reversal of Anticoagulation with Apixaban and Rivaroxaban
Thrombosis Associated with Thrombocytosis and/or Erythrocytosis
Deep Vein Thrombosis Associated with Hereditary Hemorrhagic Telangiectasia
LEFt Clinical Decision Rule for Deep Vein Thrombosis Associated with Pregnancy
Risk Score of Arlikar et al for Hospital-Associated Venous Thromboembolism (HA-VTE) for a Critically-Ill Pediatric Patient
Risk Factors of Zhang et al for Upper Extremity Deep Vein Thrombosis (UEDVT) Associated with a Peripherally-Inserted Central Catheter (PICC) in a Patient with Cancer
SWEDEHEART Score of Simonsson et al for Major In-Hospital Bleeding After Acute Myocardial Infarction
S2TOP BLEED Score for Patients Taking Antiplatelet Drugs for Noncardioembolic Stroke
ESSENCE Criteria for Bleeding Severity Associated with Heparin Therapy
CURRENT-OASIS 7 Definition of Bleeding Severity
PLATO Definitions for Bleeding Severity
Sepsis-Induced Coagulopathy (SIC)
SAMe-TT2R2 Score for Predicting INR Control During Anticoagulation with a Vitamin K Antagonist
Clinical Prediction Model of Rabinovich et al for Postthrombotic Syndrome (SOX-PTS Score)
Clinical Prediction Rule of Louzada et al for Recurrent Thromboembolism in a Patient with Cancer-Associated Venous Thromboembolism (Ottawa Thromboembolism Rule)
Clinical Prediction Model of Dreijer et al for an Elevated INR in a Hospitalized Patient Receiving a Vitamin K Antagonist
Method of Poller et al for Rapid Derivation of the International Sensitivity Index (ISI) for a Coagulometer
Possible Causes of an Erroneous International Normalized Ratio (INR)
Risk Factors of Liabeuf et al for Bleeding in a Hospitalized Patient with an Elevated INR Associated with Vitamin K Antagonist Therapy
Deep Vein Thrombosis and Pulmonary Emboli in a Patient with Pancreatitis
DASH Score of Tosetto et al for Unprovoked Venous Thromboembolism
Clinical Model of Wells et al for Deep Vein Thrombosis
Thrombosis Risk Factor Assessment of Caprini et al
Prediction Model of Constans et al for Lower Limb Deep Vein Thrombosis in an Outpatient
Revised Criteria of Wells et al for Evaluating a Patient with Suspected Deep Vein Thrombosis
Clinical Thrombosis Risk Score of Chopard et al for an Acutely-Ill Medical Patient
International Society of Thrombosis and Hemostasis (ISTH) Criteria for Major Bleeding
Criteria of Kaatz et al for Nonmajor Bleeding in an Anticoagulated Patient
Identifying an Older Adult at Low Risk for Major Bleeding During Prolonged Oral Anticoagulation Therapy Based on the Study of Gomez-Cuervo et al
ACTION Registry Model of Mathews et al for In-Hospital Bleeding During Acute Myocardial Infarction Care
Risk Factors of Pishko et al for Major Bleeding in a Patient with Suspected Heparin-Induced Thrombocytopenia (HIT)
4T Score for Heparin-Induced Thrombocytopenia (HIT)
Score of Lillo-Le Louet et al for Heparin-Induced Thrombocytopenia After Cardiopulmonary Bypass
HIT Expert Probability (HEP) Score of Cuker et al for Heparin-Induced Thrombocytopenia
Risk Factors for Severe Complications in a Patient with Heparin-Induced Thrombocytopenia (HIT)
Model of Brass et al for Predicting Intracranial Hemorrhage After Thrombolytic Therapy for Acute Myocardial Infarction
Risk Factors of Piel-Julian et al for Severe Bleeding in an Adult with Newly-Diagnosed Immune Thrombocytopenia
Criteria of Ginsberg et al for the Postthrombotic Syndrome (PTS)
Bleeding Score of Rodeghiero et al
Risk Score of Bihari et al for Coagulopathic Bleeding in Decompensated Cirrhosis and Acute-on-Chronic Liver Failure (ACLF)
Predictors of Spiezia et al for Postoperative Bleeding in a Pediatric Patient Undergoing Cardiopulmonary Bypass
Model of Heldner et al for the Diagnosis of Cerebral Venous Thrombosis
Delayed Cerebral Thrombosis Following Acute Bacterial Meningitis
Tissue Plasminogen Activator-Associated Fibrinolysis During Orthotopic Liver Transplantation
Quinine-Induced Thrombocytopenic Purpura (Cocktail Purpura)
Criteria of Lee et al for Post-Operative Coagulopathy
Grades of Lewis et al for Intraoperative Bleeding Severity (Validated Intraoperative Bleeding Scale, VIBe Scale)
Thalassemia-Related Thrombosis Risk Scoring System (TRT-RSS) of Taher et al
Risk of Thrombosis Associated with the Nephrotic Syndrome
Quick Risk Assessment Profile (qRAP) of Tachino et al to Predict Post-Traumatic Venous Thromboembolism
ICU-Venous Thromboembolism Score of Viarasilpa et al
Risk Calculator of Schlick et al for Post-Discharge Venous Thromboembolism Following Hepatectomy for Malignancy
Risk Calculator of Schlick et al for Post-Discharge Venous Thromboembolism Following Surgery for Inflammatory Bowel Disease
B2LEED3S Score for Intracranial Hemorrhage Associated with Antiplatelet Therapy
Model of Li for In-Hospital Bleeding in a Patient with Acute ST-Segment Elevation Myocardial Infarction (STEMI)
Predictive Score of Gui et al for Early Identification of Refractory Thrombotic Thrombocytopenic Purpura (TTP)
Prediction Model of Schmidt et al for Predicting Transient versus Persistent Childhood Immune Thrombocytopenia
Risk Score of Li et al for Predicting Venous Thromboembolism in a Patient with Lung Cancer
M.D. Anderson Cancer Center Cancer-Associated Venous Thromboembolism (CAT) Score
Thrombogyn Score for Predicting of Venous Thromboembolism in a Patient with Gynecologic Cancer
Model of Liu et al for Intravenous Catheter-Related Thrombosis in a Patient with Cancer
Clinical Prediction Rule of Al-Ani et al for Venous Thromboembolism in a Patient with Acute Leukemia
BASIC (Bleeding Assessment Scale in Critically Ill Children) Criteria for Bleeding Severity
IMPEDE VTE Score of Sanfilippo et al for Thrombosis in a Patient with Multiple Myeloma
Model of Jaffray et al for Pediatric Hospital-Acquired Thrombosis (HA-VTE RAM)
Model of Sultan et al for Prediction of Venous Thromboembolism in a Postpartum Woman
Risk Factors of Blondon et al for Venous Thromboembolism Following Delivery
Predictive Model of Kelly et al for Venous Thromboembolism After Fusion of the Thoracolumbar Spine
Criteria of Franco et al for Major Anticoagulant-Associated Bleeding
BleeMACS Score of Raposeiras-Roubin et al for Post-Discharge Bleeding Risk in a Patient Receiving Dual Antiplatelet Therapy (DAPT)
Intra-Abdominal Complications of the Antiphospholipid Syndrome (aPL)
Computerized Risk Scoring System of Gallo et al for Heparin-Induced Thrombocytopenia Risk (HIT-CR)
Autoimmune Heparin-Induced Thrombocytopenia (aHIT)
Criteria of Lyons et al for Sepsis-Associated Coagulopathy (SAC)
Clinical Findings of Moulis et al for Newly Diagnosed Immune Thrombocytopenia (ITP) in an Adult
Predictors of Engel et al for Postthrombotic Syndrome in a Pediatric Patient with Thrombosis
Screening for Occult Malignancy in a Patient with Idiopathic Venous Thromboembolism (SOME) Model of Ihaddadene et al
Risk Prediction Score of Jara-Palomares et al for Occult Cancer in a Patient with Venous Thromboembolism (VTE RIETE Score)
Scores of Ferreyro et al for Predicting Cancer or Death Within 1 Year of a Venous Thromboembolism (VTE)
Bone Wax as a Hemostatic Agent
DAPT (Dual Antiplatelet Therapy) Score of Liu et al for a Patient with Acute Cerebral Infarction (ACI)
L-TRiP (cast) Score of Nemeth et al for Venous Thrombosis Risk After Cast Immobilization of the Lower Extremity
Risk Factors of Barco e al for Thromboembolic Events and Major Bleeding in a Patient Receiving Home Parenteral Nutrition
CHAT Score of Gu et al for Predicting In-Hospital Venous Thrombosis After Hernia Surgery
Superior Vena Cava Syndrome (SVCS) Due to Venous Thrombosis
Risk Factors of Sochala et al for Venous Thromboembolism in a Patient with Myotonic Dystrophy
Risk of Venous Thrombosis Based on eGFR and Albuminuria
Risk Factors of Zhou et al for Early Postpartum Venous Thromboembolism
Plymouth VTE Risk Score
Bleeding Risk Score of Adam et al for a Patient with Atrial Fibrillation on Oral Anticoagulants
Scores of Rutherford et al for Bleeding Risk in a Patient Receiving a Non-Vitamin K Oral Anticoagulant (NOAC): Full Model
Scores of Rutherford et al for Bleeding Risk in a Patient Receiving a Non-Vitamin K Oral Anticoagulant (NOAC): Short Model (ABH Score)
Antiphospholipid Antibodies in a Patient with Sickle Cell Disease (SCD)
Score of Erdur et al for Risk of Thrombolysis-Associated Intracranial Hemorrhage in a Patient with an Acute Ischemic Stroke (Risk of sICH Score, RICH Score)
TURN and TURNP Scores for Prediction of Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis
BACS Score of Jara-Palomares et al for Predicting Major Bleeding Following Thrombolysis for Acute Pulmonary Embolism
Risk Score of Zwart et al for Triple Antithrombotic Therapy in a Patient with Atrial Fibrillation Who Undergoes Percutaneous Coronary Intervention (PCI)
ONKOTEV Score of Cella et al for Predicting Venous Thromboembolism in a Cancer Patient
ThroLy Score of Antic et al for Prediction of Venous Thromboembolism in a Patient with Malignant Lymphoma
CoVID-TE Risk Assessment Model for Venous Thromboembolism in a Hospitalized Patient with Cancer and COVID-19
Predictors of Abdel-Razeq et al for Venous Thromboembolism in a Patient with Testicular Germ Cell Tumor
Bentracimab for Immediate Reversal of Ticagrelor
Peripartum (Postpartum, Puerperal) Cerebral Arterial or Venous Thrombosis
Nomogram of Feng and Li for Predicting Lower Extremity Deep Vein Thrombosis in a Patient with Acute Carbon Monoxide Poisoning
Risk Factors of Eck et al for Venous Thromboembolism in a Critically Ill Patient
Nomogram of Li et al for Predicting Lower Extremity Deep Vein Thrombosis (DVT) in a Neurointensive Care Unit Patient
Nomogram of Pan et al for Lower Extremity Deep Vein Thrombosis in a Patient After an Acute Stroke
Ultrasound Criteria of Maufus et al for Recurrent Deep Vein Thrombosis (DVT)
Predictors of Tran et al for Venous Thromboembolism in a Patient in the Intensive Care Unit (ICU)
NOAC Bleeding Prediction (NBP) Score for Major Bleeding in a Patient Being Treated for Atrial Fibrillation
Disseminated Thromboembolic Storm in COVID-19
Risk Score of Atiq et al for Future Bleeding in a Patient with von Willebrand Disease (vWD)
Differential Diagnosis of Despotis et al for Hemostatic Abnormalities Associated with Cardiopulmonary Bypass (CPB)
Coagulopathy in a Patient with Mechanically Assisted Circulation (MAC)
Model of Feng and Li for Deep Vein Thrombosis in a Patient with Carbon Monoxide Poisoning
Children's Hospital Acquired Thrombosis (CHAT) Risk Assessment Model for Hospital-Acquired Venous Thromboembolism in a Critically Ill Child
Intracerebral Hemorrhage Deep Vein Thrombosis (ICH-DVT) Score of Ji et al
Thrombosis Associated with Diabetic Ketoacidosis (KA) or Hyperosmolar Hyperglycemic State (HHS)
Risk Factors of Moore et al for Venous Thromboembolism (VTE) After Adrenalectomy for an Adrenal Cortical Neoplasm
Hyperviscosity-Associated Thrombosis
PADIS-PE Score of Tromeur et al for Recurrent Venous Thromboembolism After Unprovoked Pulmonary Embolism
Bleeding Risk Prediction Score of Phetroong et al for a Patient on Long-Term Warfarin Therapy for Heart Valve Disease (HEARTS-60+3 Score)
Score of Alhousseini et al for Non-Overt Disseminated Intravascular Coagulation (DIC) in Pregnancy
Risk Factors of Go et al for Disseminated Intravascular Coagulation (DIC) in a Neonate
Score of the JSOGNH for Disseminated Intravascular Coagulation (DIC) in a Neonate
Risk Factors of Maze et al for Intracranial Hemorrhage in an Adult with Acute Leukemia
HIGH-2-LOW Score of Martens et al for Predicting Venous Thromboembolism in Allogeneic Transplant Patients After Platelet Engraftment
Predictors of Wagner et al for Postoperative Venous Thromboembolism in a Woman with Uterine Cancer
Risk Factors of Montesinos et al for Thrombosis in a Patient with Acute Promyelocytic Leukemia (APML)
Risk of Venous Thromboembolism in a Woman Receiving Tamoxifen in the Peri-Operative Period